Kazia Therapeutics (Kazia Therapeutics) FCF Yield % : -114.17 (As of May. 03, 2024)

View and export this data going back to 1999. Start your Free Trial

What is Kazia Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kazia Therapeutics's Trailing 12-Month Free Cash Flow is $-8.50 Mil, and Market Cap is $7.45 Mil. Therefore, Kazia Therapeutics's FCF Yield % for today is -114.17%.

The historical rank and industry rank for Kazia Therapeutics's FCF Yield % or its related term are showing as below:

KZIA' s FCF Yield % Range Over the Past 10 Years
Min: -285.16 Med: -50.26 Max: -5
Current: -114.17

During the past 13 years, the highest FCF Yield % of Kazia Therapeutics was -5.00%. The lowest was -285.16%. And the median was -50.26%.

KZIA's FCF Yield % is ranked worse than
85.98% of 1555 companies
in the Biotechnology industry
Industry Median: -14.42 vs KZIA: -114.17

Kazia Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Kazia Therapeutics FCF Yield % Historical Data

The historical data trend for Kazia Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kazia Therapeutics FCF Yield % Chart

Kazia Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-28.74

-18.96

-5.35

-27.45

-38.46

Kazia Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-14.66	-27.42	-118.27	-32.23	-73.19

Competitive Comparison of Kazia Therapeutics's FCF Yield %

For the Biotechnology subindustry, Kazia Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kazia Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kazia Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kazia Therapeutics's FCF Yield % falls into.

Kazia Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kazia Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-10.172	/	26.451364
	=	-38.46%

Kazia Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-4.24	*	2	/	11.58587925
	=	-73.19%

Kazia Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kazia Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kazia Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kazia Therapeutics (Kazia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (NAS:KZIA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000

Website

https://www.kaziatherapeutics.com

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Executives

Josiah T Austin	director, 10 percent owner	4673 CHRISTOPHER PLACE, DALLAS TX 75204
El Coronado Holdings, Llc	10 percent owner	4673 CHRISTOPHER PLACE, DALLAS TX 75204